🇺🇸 FDA
Pipeline program

Ferric Citrate 1 GM Oral Tablet [AURYXIA]

USRC-2021-002

Phase 3 small_molecule completed

Quick answer

Ferric Citrate 1 GM Oral Tablet [AURYXIA] for Anemia, Iron Deficiency is a Phase 3 program (small_molecule) at Akebia Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Akebia Therapeutics
Indication
Anemia, Iron Deficiency
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials